Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer have announced data from a new clinical analysis showing the benefits of Eliquis in the treatment of venous thromboembolism (VTE). Bristol-Myers Squibb Company (NYSE:BMY) belongs to Healthcare sector. Its net profit margin is 16.60% and weekly performance is 0.94%. On last trading day company shares ended up $50.65. Bristol-Myers Squibb Company (NYSE:BMY) distance from 50-day simple moving average (SMA50) … Continue reading Fast Moving Stocks : Bristol-Myers Squibb Company (NYSE:BMY), InvenSense (NYSE:INVN), Tecumseh Products Company (NASDAQ:TECU), Alere (NYSE:ALR), Stryker (NYSE:SYK)